Canadian launch for Theratechnologies' Stethos:
This article was originally published in Clinica
Theratechnologies (Canada) launched its electronic stethoscope Stethos at the Canadian Cardiovascular Society meeting in Toronto last week. The device, developed in co-operation with the Clinical Research Institute in Montreal, is sensitive to low-frequency sounds and can be combined with an interface for audio and visual reproduction. Theratechnologies estimates the world market for Stethos at Can$425 million ($327 million) and is seeking distribution partners in Japan and the US.
You may also be interested in...
The first trial of the new Flash ultra-high dose radiation therapy with Varian Medical Systems’ ProBeam particle accelerator has begun. Agum Sharda, Varian’s senior director of Flash, says the technology could be a major advance for cancer patients.
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.